RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Craniocerebral Trauma
Accession: DOID:9007621
browse the term
Definition: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.
Synonyms: exact_synonym: Craniocerebral Injuries; Craniocerebral Injury; Craniocerebral Traumas; Crushing Skull Injuries; Crushing Skull Injury; Forehead Trauma; Forehead Traumas; Frontal Region Trauma; Frontal Region Traumas; Head Injuries; Head Injury; Head Trauma; Head Traumas; Minor Head Injuries; Minor Head Injury; Multiple Head Injuries; Multiple Head Injury; Occipital Region Trauma; Occipital Region Traumas; Occipital Trauma; Occipital Traumas; Open Head Injuries; Open Head Injury; Parietal Region Trauma; Parietal Region Traumas; Superficial Head Injuries; Superficial Head Injury; Temporal Region Trauma; Temporal Region Traumas
primary_id: MESH:D006259 ; RDO:0005059
xref: EFO:0009505
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:11123362
RGD:2312784
NCBI chr24:37,211,776...37,245,938
Ensembl chr24:37,213,942...37,243,702
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:microglial cell
RGD
PMID:7830934
RGD:10045949
NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
G
POSTN
periostin
ISO
RGD
PMID:17878602
RGD:10041014
NCBI chr25:3,167,319...3,208,970
Ensembl chr25:3,167,359...3,208,411
G
SERPINC1
serpin family C member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8810955
NCBI chr 7:25,322,668...25,333,022
Ensembl chr 7:25,316,129...25,332,987
G
EPO
erythropoietin
treatment
ISO
RGD
PMID:23415790
RGD:10401075
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12503044
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
G
KCNN4
potassium calcium-activated channel subfamily N member 4
treatment
ISO
RGD
PMID:15379997
RGD:329969897
NCBI chr 1:111,391,464...111,407,612
Ensembl chr 1:111,391,159...111,407,701
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:25708984
RGD:12738361
NCBI chr18:51,404,649...51,408,240
Ensembl chr18:51,401,659...51,408,212
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
G
DRD3
dopamine receptor D3
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr33:18,369,362...18,414,465
Ensembl chr33:18,372,865...18,412,277
G
DRD4
dopamine receptor D4
ISO
RGD
PMID:26448536
RGD:13506960
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:27113205
RGD:11062140
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
C3
complement C3
ameliorates
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
IL1B
interleukin 1 beta
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
PYCARD
PYD and CARD domain containing
treatment
ISO
RGD
PMID:19401709
RGD:5491174
NCBI chr 6:17,049,352...17,051,348
Ensembl chr 6:17,049,705...17,051,240
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
ABCC8
ATP binding cassette subfamily C member 8
treatment
ISO
RGD
PMID:21107131
RGD:12791995
NCBI chr21:39,963,001...40,037,040
Ensembl chr21:39,962,947...40,036,981
G
ACAN
aggrecan
ISO
mRNA:increased expression:fascia dentata (rat)
RGD
PMID:18511192
RGD:2315807
NCBI chr 3:51,995,100...52,031,812
Ensembl chr 3:51,969,779...52,031,544
G
ACTR2
actin related protein 2
ISO
mRNA, protein:decreased expression:hippocampus (rat)
RGD
PMID:22120305
RGD:11530046
NCBI chr10:64,696,068...64,733,027
Ensembl chr10:64,696,111...64,730,553
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
RGD
PMID:16689670
RGD:2325298
NCBI chr 7:67,682,421...67,691,035
G
ADRA1A
adrenoceptor alpha 1A
ISO
mRNA:increased expression:frontal cortex
RGD
PMID:20974230
RGD:5688366
NCBI chr25:30,690,959...30,801,484
Ensembl chr25:30,693,571...30,801,486
G
AGER
advanced glycosylation end-product specific receptor
ISO
protein:increased expression:brain (rat)
RGD
PMID:22491548 PMID:22915134 PMID:24859607
RGD:7245513 RGD:7245557 RGD:8696001
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:19520144
RGD:2313020
NCBI chr12:1,104,350...1,106,179
Ensembl chr12:1,104,394...1,106,177
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
protein:increased expression:nucleus:
RGD
PMID:12091479
RGD:10053567
NCBI chr X:101,275,027...101,307,551
Ensembl chr X:101,275,017...101,307,367
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:increased phosphorylation:brain, neuron
RGD
PMID:16234845
RGD:5509090
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7909931 PMID:17188501
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
AMBP
alpha-1-microglobulin/bikunin precursor
ISO
protein:increased expression:urine
RGD
PMID:14592616
RGD:6904155
NCBI chr11:68,338,644...68,353,366
Ensembl chr11:68,338,389...68,351,994
G
ANK3
ankyrin 3
ISO
RGD
PMID:20557305
RGD:6767288
NCBI chr 4:12,166,275...12,827,175
Ensembl chr 4:12,167,550...12,827,037
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
ISO
RGD
PMID:24385964
RGD:10401136
NCBI chr30:32,741,582...32,778,883
Ensembl chr30:32,741,582...32,798,188
G
APAF1
apoptotic peptidase activating factor 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:11567033
RGD:2325751
NCBI chr15:38,026,893...38,160,842
Ensembl chr15:38,028,132...38,114,987
G
APBB1
amyloid beta precursor protein binding family B member 1
ISO
mRNA:increased expression:brain
RGD
PMID:12707777
RGD:2301208
NCBI chr21:29,719,386...29,741,658
Ensembl chr21:29,719,589...29,759,046
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11447995
NCBI chr15:17,786,808...17,789,422
Ensembl chr15:17,786,357...17,789,422
G
APOD
apolipoprotein D
ISO
mRNA, protein:increased expression:cerebral cortex, glia cell, neuron
RGD
PMID:10501208
RGD:2311202
NCBI chr33:30,490,149...30,504,804
Ensembl chr33:30,488,135...30,509,289
G
APP
amyloid beta precursor protein
ISO
protein:increased expression:hippocampus
RGD
PMID:16300758
RGD:10054281
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
G
AQP4
aquaporin 4
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21083433 PMID:21488209
RGD:5148014 RGD:5148034
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
ASIC1
acid sensing ion channel subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21307247
NCBI chr27:4,638,826...4,663,352
Ensembl chr27:4,638,812...4,648,038
G
ASTN1
astrotactin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr 7:22,455,117...22,752,044
Ensembl chr 7:22,455,499...22,757,029
G
ATG12
autophagy related 12
ISO
protein:altered localization:brain
RGD
PMID:18059433
RGD:2301217
NCBI chr11:5,531,062...5,543,034
Ensembl chr11:5,531,759...5,542,743
G
AVPR1A
arginine vasopressin receptor 1A
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:17244947
RGD:2300372
NCBI chr10:6,266,217...6,269,662
Ensembl chr10:6,265,998...6,269,662
G
BAD
BCL2 associated agonist of cell death
ISO
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:15941375
RGD:2292694
NCBI chr18:52,781,335...52,791,789
Ensembl chr18:52,781,921...52,791,405
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BCAT1
branched chain amino acid transaminase 1
ISO
Protein:increased expression:neurons
RGD
PMID:10686349
RGD:631308
NCBI chr27:22,536,297...22,643,350
Ensembl chr27:22,535,254...22,636,959
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:18093155 PMID:20888848
RGD:10054247 RGD:2293059
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
BDNF
brain derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15500971 PMID:20544832 PMID:21269288
RGD:4891136
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
BECN1
beclin 1
ISO
protein:increased expression:hippocampus CTD Direct Evidence: therapeutic protein:increased expression:neuron, astrocyte protein:increased expression:brain
RGD CTD
PMID:16874043 PMID:18500386 PMID:24221859 PMID:34929507
RGD:11558018 RGD:6483098 RGD:6483314
NCBI chr 9:20,204,203...20,215,081
Ensembl chr 9:20,204,220...20,214,236
G
BIRC5
baculoviral IAP repeat containing 5
ISO
mRNA, protein:increased expression:brain, astrocyte, neuron
RGD
PMID:15453988
RGD:2293136
NCBI chr 9:2,930,308...2,959,307
G
BMP6
bone morphogenetic protein 6
ISO
protein:increased expression:brain, astrocyte, neuron
RGD
PMID:16388909
RGD:2289020
NCBI chr35:7,780,763...7,833,095
Ensembl chr35:7,804,231...7,831,845
G
BMPR2
bone morphogenetic protein receptor type 2
ISO
mRNA:increased expression:dentate gyrus, neuron
RGD
PMID:9080432
RGD:5129488
NCBI chr37:11,342,292...11,540,199
Ensembl chr37:11,342,384...11,533,024
G
BYSL
bystin like
ISO
mRNA, protein:increased expression:substantia nigra, striatum (rat)
RGD
PMID:15305856
RGD:2316201
NCBI chr12:10,580,881...10,592,313
Ensembl chr12:10,581,217...10,591,923
G
C1QA
complement C1q A chain
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr 2:76,668,086...76,671,082
Ensembl chr 2:76,668,217...76,670,977
G
C3
complement C3
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CASK
calcium/calmodulin dependent serine protein kinase
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr X:35,939,117...36,296,438
Ensembl chr X:35,940,647...36,297,014
G
CASP12
caspase 12
severity
ISO
mRNA, protein:increased expression, increased activity:cerebral cortex, hippocampus, neuron, astrocyte
RGD
PMID:14675152
RGD:2311485
NCBI chr 5:27,162,840...27,176,964
Ensembl chr 5:27,161,700...27,177,683
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP8
caspase 8
ISO
protein:altered localization
RGD
PMID:15590916
RGD:1624191
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
CAST
calpastatin
severity
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:15307896
RGD:5509821
NCBI chr 3:12,920,514...13,031,974
Ensembl chr 3:12,922,453...13,031,959
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:brain, neuron
CTD RGD
PMID:11113322 PMID:19210118 PMID:21549006
RGD:2306999 RGD:9587789
NCBI chr 9:39,008,187...39,009,932
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:22040257
RGD:7483630
NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:hippocampus
RGD
PMID:24344922
RGD:8552265
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
CD14
CD14 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 2:35,790,505...35,792,967
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:23924471
RGD:7248749
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:11755016 PMID:25972624
RGD:11344972 RGD:8547803
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:nucleus:
RGD
PMID:9914434
RGD:8662346
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr27:33,609,154...33,613,558
Ensembl chr27:33,611,760...33,612,906
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
mRNA, protein:increased expression:cerebral cortex (mouse)
RGD
PMID:19833158
RGD:10401206
NCBI chr 1:118,846,252...118,851,045
G
CEBPB
CCAAT enhancer binding protein beta
ISO
mRNA, protein:increased expression:cerebral cortex (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19833158 PMID:21549006
RGD:10401206
NCBI chr24:36,661,294...36,663,162
Ensembl chr24:36,661,616...36,662,656
G
CES1
carboxylesterase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 2:60,276,723...60,305,970
Ensembl chr 2:60,236,150...60,321,178
G
CFB
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17474994
NCBI chr12:1,400,143...1,406,267
G
CHRM2
cholinergic receptor muscarinic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr16:11,515,727...11,665,651
Ensembl chr16:11,515,426...11,664,977
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:36,852,082...37,164,930
Ensembl chr 3:36,852,543...36,978,399
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:increased expression:hippocampus
RGD
PMID:20215974
RGD:6483336
NCBI chr 9:20,888,350...20,896,139
Ensembl chr 9:20,886,574...20,896,079
G
COMT
catechol-O-methyltransferase
ISO
protein:increased expression:hippocampus
RGD
PMID:17240060
RGD:2289740
NCBI chr26:29,359,930...29,381,854
Ensembl chr26:29,360,356...29,366,008
G
CRP
C-reactive protein
disease_progression
ISO
RGD
PMID:24456846
RGD:9585646
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
CSF2
colony stimulating factor 2
disease_progression
ISO
RGD
PMID:21515263
RGD:5686795
NCBI chr11:20,342,880...20,346,959
Ensembl chr11:20,344,648...20,346,959
G
CSF3
colony stimulating factor 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21549006 PMID:24239694
RGD:11039431
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
protein:altered expression:cerebral cortex
RGD
PMID:19473238
RGD:5686860
NCBI chr30:38,465,486...38,498,365
Ensembl chr30:38,465,241...38,497,971
G
CUL5
cullin 5
ISO
mRNA, protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17010517
RGD:2301432
NCBI chr 5:24,393,692...24,477,595
Ensembl chr 5:24,396,823...24,488,043
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
ISO
mRNA:increased expression:hindbrain
RGD
PMID:16329132
RGD:1599699
NCBI chr30:37,474,997...37,487,028
Ensembl chr30:37,473,901...37,487,507
G
DAB2
DAB adaptor protein 2
ISO
RGD
PMID:15774263
RGD:7243841
NCBI chr 4:69,625,874...69,648,349
Ensembl chr 4:69,625,527...69,648,321
G
DNMT1
DNA methyltransferase 1
ISO
RGD
PMID:19429151
RGD:9588608
NCBI chr20:50,872,213...50,928,352
Ensembl chr20:50,879,527...50,928,029
G
DPYSL2
dihydropyrimidinase like 2
ISO
protein:increased degradation:cerebral cortex, hippocampus
RGD
PMID:17402852
RGD:2303056
NCBI chr25:30,900,347...31,038,256
Ensembl chr25:30,903,253...31,038,144
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:18509630
RGD:2311580
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
G
DUSP5
dual specificity phosphatase 5
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:12503083
RGD:2317873
NCBI chr28:21,829,891...21,844,590
Ensembl chr28:21,829,921...21,841,454
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr 8:41,354,400...41,371,676
Ensembl chr 8:41,351,244...41,371,056
G
ELK1
ETS transcription factor ELK1
ISO
RGD
PMID:15362724
RGD:7488910
NCBI chr X:41,256,205...41,270,656
Ensembl chr X:41,257,482...41,270,776
G
ENO2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34533065
NCBI chr27:38,120,404...38,128,543
Ensembl chr27:38,119,413...38,129,182
G
EPAS1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:22960363
RGD:10395371
NCBI chr10:48,550,836...48,636,776
Ensembl chr10:48,551,410...48,634,844
G
EPHA4
EPH receptor A4
ISO
protein:increased expression, increased activity:astrocyte
RGD
PMID:22318127
RGD:5688763
NCBI chr37:27,670,143...27,809,642
Ensembl chr37:27,677,566...27,809,646
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:21075124
RGD:5688356
NCBI chr25:30,045,040...30,107,110
Ensembl chr25:30,045,291...30,107,110
G
EPO
erythropoietin
treatment
ISO
CTD Direct Evidence: therapeutic mRNA:increased expression:brain:
CTD RGD
PMID:18093155 PMID:20833152 PMID:23063952
RGD:10401061 RGD:2293059
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
G
EPOR
erythropoietin receptor
ISO
mRNA:increased expression:brain:
RGD
PMID:18093155
RGD:2293059
NCBI chr20:49,945,777...49,950,856
Ensembl chr20:49,945,777...49,950,856
G
F2
coagulation factor II, thrombin
severity
ISO
RGD
PMID:21355766
RGD:5147766
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
FAS
Fas cell surface death receptor
ISO
associated with Hyperoxia mRNA:increased expression:hippocampus
RGD
PMID:16078565 PMID:19107989
RGD:1600354 RGD:8662854
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FGF2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21269288
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
FMR1
Fragile X messenger ribonucleoprotein 1
ISO
protein:altered localization:hippocampus (rat)
RGD
PMID:16510718
RGD:11667962
NCBI chr X:116,249,079...116,287,008
Ensembl chr X:116,249,142...116,321,439
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9630518
NCBI chr 8:48,330,856...48,334,273
Ensembl chr 8:48,331,026...48,333,467
G
FOXP1
forkhead box P1
treatment
ISO
RGD
PMID:26842647
RGD:11561903
NCBI chr20:20,438,631...21,020,516
Ensembl chr20:20,788,433...21,016,397
G
G6PD
glucose-6-phosphate dehydrogenase
ISO
protein:decreased expression:hippocampus
RGD
PMID:18501200
RGD:2307353
NCBI chr X:122,217,317...122,231,862
Ensembl chr X:122,205,683...122,231,678
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:33,878,948...34,101,987
Ensembl chr 3:33,878,904...34,097,764
G
GABRG3
gamma-aminobutyric acid type A receptor subunit gamma3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:32,956,061...33,641,971
Ensembl chr 3:32,964,122...33,642,686
G
GDNF
glial cell derived neurotrophic factor
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr 4:70,966,694...70,991,860
Ensembl chr 4:70,971,432...70,989,714
G
GJA1
gap junction protein alpha 1
treatment
ISO
RGD
PMID:23485053
RGD:8662424
NCBI chr 1:60,941,772...60,944,694
Ensembl chr 1:60,929,097...60,942,936
G
GJA5
gap junction protein alpha 5
ISO
protein:increased expression:cerebral artery
RGD
PMID:21895483
RGD:7207391
NCBI chr17:58,289,327...58,305,315
Ensembl chr17:58,289,327...58,305,315
G
GPX1
glutathione peroxidase 1
ISO
mRNA:decreased expression:hippocampus, neuron
RGD
PMID:15791111
RGD:2306624
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GRM8
glutamate metabotropic receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr14:8,982,180...9,719,813
Ensembl chr14:8,983,802...9,719,357
G
GSK3B
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22643085 PMID:24675465
RGD:10045646
NCBI chr33:23,458,369...23,659,878
Ensembl chr33:23,463,767...23,659,666
G
GSN
gelsolin
ISO
RGD
PMID:14588109
RGD:1599864
NCBI chr11:74,248,227...74,268,129
Ensembl chr11:74,233,457...74,268,129
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:11726545
RGD:9686434
NCBI chr 4:64,777,069...65,162,603
Ensembl chr 4:64,775,577...65,160,444
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:22915134
RGD:7245513
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:18562561
RGD:5508455
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:23470432
RGD:10755702
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:cerebral white matter (rat)
RGD
PMID:22067617
RGD:5688785
NCBI chr11:21,290,603...21,363,701
Ensembl chr11:21,290,621...21,505,122
G
HSPB1
heat shock protein family B (small) member 1
ISO
RGD
PMID:11746764
RGD:6480530
NCBI chr 6:7,487,164...7,488,576
Ensembl chr 6:7,487,250...7,488,576
G
HTR7
5-hydroxytryptamine receptor 7
ISO
RGD
PMID:22465320
RGD:6482178
NCBI chr28:5,438,872...5,524,385
Ensembl chr28:5,440,388...5,524,191
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:brain:
RGD
PMID:16230799
RGD:11522716
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
IFNL3
interferon lambda 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
G
IGF1
insulin like growth factor 1
treatment
ISO
human protein in a rat model
RGD
PMID:9344566
RGD:12904928
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF2
insulin like growth factor 2
ISO
mRNA:decreased expression:brain
RGD
PMID:11123717
RGD:5509972
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
IL10
interleukin 10
treatment severity
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21549006 PMID:23075771 PMID:23971414
RGD:7364822 RGD:7364983
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL12RB2
interleukin 12 receptor subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 5:43,197,034...43,269,571
Ensembl chr 5:43,197,034...43,257,594
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr X:87,747,373...87,776,797
Ensembl chr X:87,747,373...87,776,798
G
IL16
interleukin 16
ISO
RGD
PMID:17983426
RGD:5024939
NCBI chr 3:56,473,485...56,575,504
Ensembl chr 3:56,473,486...56,575,104
G
IL17RD
interleukin 17 receptor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr20:33,240,728...33,306,727
Ensembl chr20:33,240,767...33,303,404
G
IL18
interleukin 18
severity
ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500
RGD:2315917
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL18R1
interleukin 18 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr10:40,614,336...40,653,300
Ensembl chr10:40,615,312...40,653,454
G
IL1A
interleukin 1 alpha
ISO
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16024175 PMID:21549006
RGD:2311098
NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
G
IL1B
interleukin 1 beta
ISO
mRNA, protein:increased expression:brain protein:increased expression:brain, cerebrospinal fluid CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:cerebral cortex
RGD CTD
PMID:16024175 PMID:17612572 PMID:19800810 PMID:21549006 PMID:22503903
RGD:1626652 RGD:2311098 RGD:6482651
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1R1
interleukin 1 receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr10:40,825,986...40,897,898
Ensembl chr10:40,827,377...40,897,596
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25665855
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
IL2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
G
IL3
interleukin 3
disease_progression
ISO
protein: increased expression: brain: microdialysis perfusate
RGD
PMID:20717122 PMID:21515263
RGD:5686795 RGD:5686886
NCBI chr11:20,330,480...20,332,668
Ensembl chr11:20,330,480...20,332,668
G
IL31RA
interleukin 31 receptor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 2:43,113,194...43,198,200
Ensembl chr 2:43,144,071...43,193,293
G
IL4
interleukin 4
ISO
protein:decreased expression:plasma
RGD
PMID:24519543
RGD:10402802
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL5
interleukin 5
treatment
ISO
RGD
PMID:24530657 PMID:24602693
RGD:11522766 RGD:11522770
NCBI chr11:20,825,469...20,827,269
Ensembl chr11:20,825,469...20,827,269
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:cerebrospinal fluid (rat)
CTD RGD
PMID:10027774 PMID:19800810 PMID:21549006 PMID:23159883
RGD:11049549
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr29:26,384,493...26,422,586
Ensembl chr29:26,384,493...26,422,737
G
IRF1
interferon regulatory factor 1
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:cerebral cortex
CTD RGD
PMID:12503083 PMID:21549006
RGD:2317873
NCBI chr11:20,773,801...20,781,106
Ensembl chr11:20,760,120...20,781,608
G
JAK2
Janus kinase 2
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 5:50,966,698...50,968,939
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:20861444
RGD:8662901
NCBI chr38:22,114,718...22,143,625
Ensembl chr38:22,130,508...22,140,813
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:cerebral cortex
RGD
PMID:19733172 PMID:21307798
RGD:5684382 RGD:5684402
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
LEP
leptin
ISO
RGD
PMID:21276361
RGD:5128517
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
LOC102151342
ATP synthase subunit d, mitochondrial-like
treatment
ISO
RGD
PMID:26813465
RGD:13800884
NCBI chr 7:66,856,651...66,857,162
G
LOC477072
serotransferrin
ISO
RGD
PMID:22538758
RGD:7244386
NCBI chr23:30,658,250...30,683,816
Ensembl chr23:30,595,704...30,683,845
G
LOC611538
C-type lectin domain family 4 member E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr27:37,561,445...37,568,652
Ensembl chr27:37,563,038...37,568,463
G
LOC611642
interleukin-9 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 6:40,425,072...40,437,917
G
LSG1
large 60S subunit nuclear export GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr33:31,078,384...31,117,093
Ensembl chr33:31,087,349...31,117,095
G
LY86
lymphocyte antigen 86
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr35:6,627,744...6,687,170
Ensembl chr35:6,627,598...6,687,166
G
MAG
myelin associated glycoprotein
susceptibility
ISO
RGD
PMID:17156367
RGD:9685230
NCBI chr 1:117,288,306...117,301,975
Ensembl chr 1:117,288,343...117,302,386
G
MAP1B
microtubule associated protein 1B
ISO
protein:increased expression, increased phosphorylation:brain
RGD
PMID:10906717
RGD:2304029
NCBI chr 2:55,175,000...55,258,160
Ensembl chr 2:55,174,837...55,253,975
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
ISO
RGD
PMID:24221859
RGD:11558018
NCBI chr24:23,672,343...23,673,937
Ensembl chr24:23,633,579...23,673,921
G
MAP2
microtubule associated protein 2
ISO
protein:decreased expression:cerebral cortex, neuron
RGD
PMID:20568963 PMID:21401443
RGD:6483087 RGD:6483089
NCBI chr37:17,316,899...17,611,360
Ensembl chr37:17,466,678...17,607,803
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:26100626 PMID:27000704 PMID:33414375
RGD:155791672 RGD:155804286 RGD:155882440
NCBI chr12:49,669,849...49,740,039
Ensembl chr12:49,672,389...49,739,850
G
MBL1
mannose binding lectin 1
disease_progression
ISO
RGD
PMID:18183030
RGD:12910935
NCBI chr 4:29,419,886...29,424,377
G
MBP
myelin basic protein
ISO
RGD
PMID:18583256
RGD:7349333
NCBI chr 1:2,841,801...2,952,553
Ensembl chr 1:2,846,589...2,951,860
G
MDM2
MDM2 proto-oncogene
ISO
protein:increased expression:brain cortex (rat)
RGD
PMID:15165363
RGD:2317397
NCBI chr10:10,936,288...10,963,118
Ensembl chr10:10,893,719...10,962,596
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:15922484
RGD:1641989
G
MIR132
microRNA mir-132
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 9:46,153,531...46,153,590
Ensembl chr 9:46,153,511...46,153,611
G
MIR144
microRNA mir-144
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr 9:43,031,035...43,031,094
Ensembl chr 9:43,031,035...43,031,094
G
MIR153
microRNA mir-153
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr16:19,932,378...19,932,457
Ensembl chr16:19,932,378...19,932,457
G
MIR183
microRNA mir-183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr14:7,068,542...7,068,603
Ensembl chr14:7,068,519...7,068,625
G
MMP9
matrix metallopeptidase 9
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16671440 PMID:19631748 PMID:24661104
RGD:13207312 RGD:1582656
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:11686499
RGD:2302298
NCBI chr MT:7,034...7,717
Ensembl chr MT:7,034...7,717
G
MT-III
transcription initiation factor TFIID subunit 4
treatment
ISO
RGD
PMID:10218634 PMID:10595827 PMID:16314047
RGD:6480628 RGD:9685803 RGD:9685805
NCBI chr 2:59,624,845...59,630,386
G
MT2A
metallothionein 1H
ISO
mRNA:increased expression:dentate gyrus (rat) mRNA:increased expression:liver (mouse)
RGD
PMID:15650329 PMID:22363575
RGD:6483812 RGD:6483847
NCBI chr 2:59,607,926...59,608,825
Ensembl chr 2:59,607,927...59,626,727
G
MYOC
myocilin
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12799138
RGD:7401267
NCBI chr 7:27,335,314...27,346,821
Ensembl chr 7:27,335,314...27,346,820
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:lung:
RGD
PMID:18787991 PMID:25089700
RGD:11576302 RGD:5134971
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NGB
neuroglobin
severity
ISO
RGD
PMID:21915648
RGD:9743963
NCBI chr 8:50,081,960...50,086,071
Ensembl chr 8:50,081,960...50,085,435
G
NGFR
nerve growth factor receptor
treatment
ISO
RGD
PMID:23940017
RGD:10414074
NCBI chr 9:25,598,468...25,621,021
Ensembl chr 9:25,601,074...25,623,274
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOX4
NADPH oxidase 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36762617
NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
G
NPPB
natriuretic peptide B
ISO
associated with lung diseases;protein:increased expression:serum: CTD Direct Evidence: therapeutic
RGD CTD
PMID:19803787 PMID:23837838
RGD:7247620
NCBI chr 2:84,395,844...84,397,473
G
NPY
neuropeptide Y
ISO
protein:increased expression:adrenal medulla
RGD
PMID:23570732
RGD:10448961
NCBI chr14:37,824,579...37,831,289
Ensembl chr14:37,823,861...37,831,443
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
mRNA:increased expression:lung associated with Subarachnoid Hemorrhage
RGD
PMID:18787991 PMID:20864352
RGD:11035222 RGD:5134971
NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
G
NT5E
5'-nucleotidase ecto
ISO
protein:altered expression:cerebral cortex (rat)
RGD
PMID:21337375
RGD:5134348
NCBI chr12:45,491,028...45,520,019
Ensembl chr12:45,491,733...45,518,405
G
P2RY1
purinergic receptor P2Y1
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:19115395
RGD:2315811
NCBI chr23:47,249,496...47,253,203
Ensembl chr23:47,249,496...47,253,203
G
PALLD
palladin, cytoskeletal associated protein
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:12932445
RGD:2325786
NCBI chr25:19,147,310...19,568,712
Ensembl chr25:19,146,898...19,553,679
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17640816
NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:increased expression:brain:
RGD
PMID:11421591
RGD:9835358
NCBI chr15:22,114,014...22,159,287
G
PDE4D
phosphodiesterase 4D
ISO
mRNA, protein:alternative form, decreased phosphorylation:brain
RGD
PMID:23057870
RGD:7327147
NCBI chr 2:45,843,767...47,245,263
Ensembl chr 2:45,846,294...46,949,912
G
PDGFA
platelet derived growth factor subunit A
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 6:16,271,082...16,293,246
Ensembl chr 6:16,270,104...16,292,396
G
PDGFB
platelet derived growth factor subunit B
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr10:25,798,877...25,819,422
Ensembl chr10:25,798,938...25,817,746
G
PDGFRA
platelet derived growth factor receptor alpha
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr13:46,729,722...46,775,828
Ensembl chr13:46,730,703...46,773,278
G
PDGFRB
platelet derived growth factor receptor beta
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 4:58,925,922...58,963,639
Ensembl chr 4:58,926,351...58,962,283
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22658532
RGD:6484732
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PGLYRP1
peptidoglycan recognition protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 1:109,614,404...109,618,242
Ensembl chr 1:109,614,437...109,618,242
G
PGR
progesterone receptor
ISO
RGD
PMID:23211561
RGD:7248711
NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
G
PHB1
prohibitin 1
ISO
protein:increased oxidation:cerebral cortex
RGD
PMID:17518533
RGD:2292409
NCBI chr 9:25,525,711...25,536,722
Ensembl chr 9:25,526,649...25,536,722
G
PHB2
prohibitin 2
ISO
RGD
PMID:24566151
RGD:12903261
NCBI chr27:38,075,769...38,080,440
Ensembl chr27:38,075,652...38,080,109
G
PIAS1
protein inhibitor of activated STAT 1
ISO
protein:decreased expression:brain, nucleus
RGD
PMID:21545521
RGD:8693413
NCBI chr30:32,116,363...32,232,530
Ensembl chr30:32,119,311...32,228,945
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
agonist more effective in combination with simvastatin
RGD
PMID:18562561
RGD:5508455
NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
G
PPARGC1A
PPARG coactivator 1 alpha
treatment
ISO
protein:decreased expression:frontal cortex (rat)
RGD
PMID:22642418 PMID:24345766
RGD:10059630 RGD:6484257
NCBI chr 3:85,645,942...86,284,570
Ensembl chr 3:86,016,140...86,281,269
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism protein: :hippocampus
CTD RGD
PMID:14499481 PMID:19751097
RGD:6483311
NCBI chr32:22,688,141...22,996,693
Ensembl chr32:22,688,143...22,996,688
G
PRF1
perforin 1
ISO
RGD
PMID:20537642
RGD:6482807
NCBI chr 4:21,497,865...21,502,429
Ensembl chr 4:21,498,249...21,500,864
G
PTGER3
prostaglandin E receptor 3
ISO
protein:increased expression:striatum, microglia (rat)
RGD
PMID:15234107
RGD:9850280
NCBI chr 6:74,932,789...74,986,573
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:microglia, macrophage protein:increased expression:microglial cells, macrophage, endothelial cell
RGD
PMID:11565600 PMID:12005397 PMID:19719848
RGD:5688162 RGD:5688239 RGD:5688242
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12410334 PMID:19719848 PMID:20810888 PMID:21549006 PMID:21866634
RGD:5508191 RGD:5688162
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTPRZ1
protein tyrosine phosphatase receptor type Z1
ISO
RGD
PMID:12088737
RGD:727637
NCBI chr14:59,769,553...59,944,111
Ensembl chr14:59,827,650...59,943,315
G
RCHY1
ring finger and CHY zinc finger domain containing 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr32:67,136...94,053
Ensembl chr32:67,509...93,987
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:ileum
RGD
PMID:18288455
RGD:2298787
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr28:3,946,132...3,995,505
Ensembl chr28:3,947,232...3,994,210
G
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17929039
RGD:2298888
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
G
ROBO1
roundabout guidance receptor 1
ISO
mRNA:increased expression:brain protein:increased expression:brain, immune cell
RGD
PMID:16262652 PMID:26550694
RGD:2316136 RGD:243048437
NCBI chr31:8,082,363...8,594,623
Ensembl chr31:7,626,126...8,593,728
G
ROBO2
roundabout guidance receptor 2
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr31:9,415,390...11,047,710
Ensembl chr31:9,419,026...11,022,392
G
ROBO3
roundabout guidance receptor 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 5:9,563,353...9,579,111
Ensembl chr 5:9,563,345...9,579,289
G
RPS27A
ribosomal protein S27a
ISO
mRNA:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17936732
RGD:11041870
NCBI chr10:56,132,924...56,135,327
Ensembl chr10:56,132,894...56,135,327
G
S100B
S100 calcium binding protein B
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:11520488 PMID:21783483 PMID:21976236
RGD:5508761
NCBI chr31:39,783,990...39,788,289
Ensembl chr31:39,784,506...39,788,183
G
SELE
selectin E
ISO
protein:increased expression:brain
RGD
PMID:19107536
RGD:2313599
NCBI chr 7:28,888,503...28,898,787
Ensembl chr 7:28,888,197...28,898,786
G
SERPINC1
serpin family C member 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21534203
NCBI chr 7:25,322,668...25,333,022
Ensembl chr 7:25,316,129...25,332,987
G
SERPINF1
serpin family F member 1
treatment
ISO
human gene in a rat model protein:altered expression:cerebellum (rat)
RGD
PMID:17709187 PMID:20142768
RGD:8612994 RGD:8622925
NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:17970622
RGD:9497541
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
SKP2
S-phase kinase associated protein 2
ISO
protein:increased expression:brain
RGD
PMID:19852587
RGD:2315049
NCBI chr 4:72,352,966...72,386,469
Ensembl chr 4:72,352,986...72,386,307
G
SLC18A3
solute carrier family 18 member A3
ISO
protein:decreased expression:brain
RGD
PMID:18848922
RGD:5686682
NCBI chr28:1,476,873...1,478,538
Ensembl chr28:1,476,774...1,478,505
G
SLIT1
slit guidance ligand 1
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr28:10,351,758...10,519,322
Ensembl chr28:10,351,821...10,519,313
G
SLIT2
slit guidance ligand 2
exacerbates
ISO
RGD
PMID:26550694
RGD:243048437
NCBI chr 3:88,964,707...89,311,817
Ensembl chr 3:88,966,232...89,312,955
G
SLIT3
slit guidance ligand 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 4:42,506,680...43,099,053
Ensembl chr 4:42,508,426...43,094,714
G
SNCA
synuclein alpha
ISO
RGD
PMID:14637093 PMID:25089700
RGD:11576302 RGD:6480195
NCBI chr32:12,915,871...13,079,338
Ensembl chr32:12,916,215...13,060,383
G
SNCB
synuclein beta
ISO
RGD
PMID:14637093
RGD:6480195
NCBI chr 4:36,710,236...36,719,455
Ensembl chr 4:36,616,039...36,764,501
G
SNCG
synuclein gamma
ISO
RGD
PMID:14637093
RGD:6480195
NCBI chr 4:34,604,867...34,608,851
Ensembl chr 4:34,605,091...34,608,842
G
SNW1
SNW domain containing 1
ISO
mRNA, protein:increased expression:cerebral cortex (rat)
RGD
PMID:22965216
RGD:11035237
NCBI chr 8:50,478,924...50,512,360
Ensembl chr 8:50,479,338...50,512,243
G
SOD1
superoxide dismutase 1
ISO
RGD
PMID:16248885
RGD:1581214
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16248885 PMID:24462953
RGD:1581214
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:brain, blood vessel
RGD
PMID:9704602
RGD:2300066
NCBI chr 4:57,659,541...57,682,147
Ensembl chr 4:57,659,650...57,681,711
G
SSTR2
somatostatin receptor 2
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr 9:6,989,488...7,004,851
Ensembl chr 9:6,996,874...7,000,778
G
SSTR3
somatostatin receptor 3
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr10:27,324,067...27,332,570
Ensembl chr10:27,329,174...27,330,451
G
STAT1
signal transducer and activator of transcription 1
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr37:1,513,438...1,549,837
Ensembl chr37:1,507,219...1,550,178
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased phosphorylation:brain
RGD
PMID:21596098 PMID:22145815 PMID:22827467
RGD:6483023 RGD:6892706 RGD:8694312
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
G
STRN
striatin
ISO
RGD
PMID:16351572
RGD:2311293
NCBI chr17:29,264,693...29,364,273
Ensembl chr17:29,272,833...29,332,869
G
TARDBP
TAR DNA binding protein
ISO
RGD
PMID:22101322
RGD:5687195
NCBI chr 2:84,987,752...84,998,136
Ensembl chr 2:84,989,952...84,998,593
G
TH
tyrosine hydroxylase
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:21047500
RGD:5128822
NCBI chr18:46,327,136...46,334,973
Ensembl chr18:46,327,137...46,335,602
G
THBD
thrombomodulin
onset
ISO
RGD
PMID:17895610
RGD:5685007
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
G
TICAM2
toll like receptor adaptor molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr11:5,312,383...5,313,099
Ensembl chr11:5,312,383...5,313,099
G
TIMP1
TIMP metallopeptidase inhibitor 1
ISO
mRNA:increased expression:brain, astrocytes
RGD
PMID:10719361
RGD:2290468
NCBI chr X:41,201,623...41,205,314
Ensembl chr X:41,201,638...41,205,310
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
mRNA:increased expression:brain, neuron, microglial cell
RGD
PMID:10719361
RGD:2290468
NCBI chr 9:2,521,882...2,533,883
Ensembl chr 9:2,521,882...2,533,989
G
TJP1
tight junction protein 1
ISO
RGD
PMID:19889224
RGD:2325128
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
G
TLR1
toll like receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 3:73,504,359...73,544,822
Ensembl chr 3:73,539,715...73,544,624
G
TLR2
toll like receptor 2
ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18316784 PMID:21549006
RGD:2312713
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TLR4
toll like receptor 4
ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18316784 PMID:21549006
RGD:2312713
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TLR9
toll like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10674461 PMID:19800810 PMID:21549006
RGD:13825262
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF13B
TNF receptor superfamily member 13B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 5:42,448,976...42,483,792
Ensembl chr 5:42,449,053...42,482,740
G
TNFRSF13C
TNF receptor superfamily member 13C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr10:23,430,960...23,434,972
Ensembl chr10:23,433,052...23,438,946
G
TNFRSF14
TNF receptor superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 5:57,386,190...57,416,864
Ensembl chr 5:57,411,529...57,416,512
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17074049 PMID:21549006
RGD:1624183
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
G
TNFSF12
tumor necrosis factor (ligand) superfamily, member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 5:32,473,543...32,481,596
Ensembl chr 5:32,473,083...32,481,121
G
TRAF4
TNF receptor associated factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 9:42,933,638...42,940,033
Ensembl chr 9:42,933,750...42,939,520
G
TRPM2
transient receptor potential cation channel subfamily M member 2
ISO
mRNA, protein:increased expression:cerebral cortex, hippocampus
RGD
PMID:20309649
RGD:9999437
NCBI chr31:38,201,075...38,224,076
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
ISO
mRNA:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:17936732
RGD:11041870
NCBI chr20:44,477,128...44,480,023
Ensembl chr20:44,477,130...44,479,948
G
UCP2
uncoupling protein 2
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12858170
RGD:7204436
NCBI chr21:24,304,410...24,311,392
Ensembl chr21:24,304,457...24,311,128
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12230324 PMID:18065154
RGD:1580574
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VEGFB
vascular endothelial growth factor B
ISO
mRNA, protein:increased expression:brain
RGD
PMID:12230324
RGD:1580574
NCBI chr18:52,821,348...52,824,649
Ensembl chr18:52,821,365...52,824,655
G
VIM
vimentin
ISO
protein:increased expression:brain
RGD
PMID:15527750 PMID:19728994
RGD:6480519 RGD:6480527
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
G
XDH
xanthine dehydrogenase
treatment
ISO
RGD
PMID:26528358
RGD:13208950
NCBI chr17:24,900,708...24,960,748
Ensembl chr17:24,901,447...24,971,935
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:polymorphism:exon:
RGD
PMID:9214529
RGD:7495763
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
TARDBP
TAR DNA binding protein
ISO
protein:increased expression:brain
RGD
PMID:20720505
RGD:5687179
NCBI chr 2:84,987,752...84,998,136
Ensembl chr 2:84,989,952...84,998,593
G
BECN1
beclin 1
ISO
protein:increased expression:neuron
RGD
PMID:16004578
RGD:6483315
NCBI chr 9:20,204,203...20,215,081
Ensembl chr 9:20,204,220...20,214,236
G
GFAP
glial fibrillary acidic protein
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr 9:18,569,868...18,579,463
Ensembl chr 9:18,569,892...18,579,461
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
human protein in a rat model
RGD
PMID:17014847
RGD:13504858
NCBI chr28:12,352,658...12,377,960
Ensembl chr28:12,352,659...12,414,579
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGFBP3
insulin like growth factor binding protein 3
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
G
VIM
vimentin
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
G
ALDH3A1
aldehyde dehydrogenase 3 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28038895
NCBI chr 5:40,466,237...40,474,272
Ensembl chr 5:40,466,237...40,474,457
G
TP63
tumor protein p63
ISO
RGD
PMID:12167247
RGD:11568649
NCBI chr34:21,766,861...21,985,095
Ensembl chr34:21,766,496...21,983,046
G
IFNG
interferon gamma
ISO
mRNA,protein:increased expression:corneal
RGD
PMID:15832292
RGD:8157597
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
BMP4
bone morphogenetic protein 4
ISO
mRNA:increased expression:superior cervical ganglion
RGD
PMID:16420416
RGD:2289006
NCBI chr 8:29,997,563...30,254,307
Ensembl chr 8:29,997,569...30,004,557
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:15153618
RGD:4891994
NCBI chr 2:59,022,794...59,032,095
Ensembl chr 2:59,022,794...59,032,095
G
S100B
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr31:39,783,990...39,788,289
Ensembl chr31:39,784,506...39,788,183
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:22553604
RGD:7364851
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:retina
RGD
PMID:9618720
RGD:7794723
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:cornea, neutrophil, macrophage (rat)
RGD
PMID:24194635
RGD:8552904
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
FGF2
fibroblast growth factor 2
ISO
protein:increased expression:lens
RGD
PMID:15273655
RGD:8655664
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
MIR183
microRNA mir-183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr14:7,068,542...7,068,603
Ensembl chr14:7,068,519...7,068,625
G
MIR96
microRNA mir-96
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr14:7,068,754...7,068,842
Ensembl chr14:7,068,754...7,068,842
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:18658087
RGD:8552893
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:19427307
RGD:2325258
NCBI chr 7:67,682,421...67,691,035
G
ATF2
activating transcription factor 2
ISO
RGD
PMID:9813301
RGD:10047413
NCBI chr36:19,032,376...19,103,382
Ensembl chr36:19,010,717...19,103,292
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:19922414
RGD:6892922
NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
G
CD59
CD59 molecule
ISO
mRNA, protein:increased expression:facial VII nucleus
RGD
PMID:9846834
RGD:1600495
NCBI chr18:33,977,433...33,999,145
Ensembl chr18:33,977,480...33,998,329
G
CLU
clusterin
ISO
protein:increased expression:neuron,astrocyte
RGD
PMID:10800205
RGD:408418725
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
CSF1
colony stimulating factor 1
ISO
protein:increased expression:facial VII nerve, microglial cell
RGD
PMID:20831658
RGD:5131509
NCBI chr 6:42,028,454...42,047,028
Ensembl chr 6:42,034,149...42,049,371
G
CTSS
cathepsin S
ISO
RGD
PMID:17539023
RGD:5686912
NCBI chr17:59,893,840...59,910,878
Ensembl chr17:59,893,840...59,910,849
G
GFRA1
GDNF family receptor alpha 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr28:26,707,592...26,910,029
Ensembl chr28:26,709,645...26,909,992
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:21562589
RGD:8548634
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
G
MT-III
transcription initiation factor TFIID subunit 4
treatment
ISO
RGD
PMID:14625437
RGD:9685806
NCBI chr 2:59,624,845...59,630,386
G
NDUFA5
NADH:ubiquinone oxidoreductase subunit A5
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:8875451
RGD:2302319
NCBI chr14:11,995,862...12,008,257
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr28:3,946,132...3,995,505
Ensembl chr28:3,947,232...3,994,210
G
ACVR1B
activin A receptor type 1B
ISO
RGD
PMID:9013782
RGD:151665480
NCBI chr27:3,009,710...3,029,726
Ensembl chr27:2,994,857...3,042,396
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr31:22,169,821...22,178,879
Ensembl chr31:22,170,381...22,178,945
G
AIF1
allograft inflammatory factor 1
ISO
RGD
PMID:9698327
RGD:704401
NCBI chr12:1,104,350...1,106,179
Ensembl chr12:1,104,394...1,106,177
G
CSNK2B
casein kinase 2 beta
ISO
RGD
PMID:11068334
RGD:11565824
NCBI chr12:1,149,467...1,154,417
Ensembl chr12:1,149,548...1,154,418
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
G
GFRA1
GDNF family receptor alpha 1
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr28:26,707,592...26,910,029
Ensembl chr28:26,709,645...26,909,992
G
IL1R1
interleukin 1 receptor type 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr10:40,825,986...40,897,898
Ensembl chr10:40,827,377...40,897,596
G
MCAM
melanoma cell adhesion molecule
ISO
RGD
PMID:10076889
RGD:7364787
NCBI chr 5:14,590,252...14,598,901
Ensembl chr 5:14,567,238...14,598,149
G
MME
membrane metalloendopeptidase
ISO
RGD
PMID:8201016
RGD:13801045
NCBI chr23:48,966,222...49,059,919
Ensembl chr23:48,971,066...49,059,919
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr20:48,416,730...48,425,237
Ensembl chr20:48,409,045...48,426,669
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr 6:63,615,445...63,729,386
Ensembl chr 6:63,618,323...63,730,146
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr28:3,946,132...3,995,505
Ensembl chr28:3,947,232...3,994,210
G
SMAD1
SMAD family member 1
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr15:44,093,491...44,171,177
Ensembl chr15:44,095,497...44,170,098
G
SMAD2
SMAD family member 2
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 7:43,696,883...43,778,063
Ensembl chr 7:43,700,445...43,769,983
G
SMAD3
SMAD family member 3
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr30:31,246,313...31,360,098
Ensembl chr30:31,245,657...31,363,337
G
SMAD4
SMAD family member 4
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405
G
SMAD7
SMAD family member 7
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 7:79,706,485...79,734,673
Ensembl chr 7:79,706,705...79,734,749
G
SMAD9
SMAD family member 9
ISO
mRNA:decreased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr25:3,768,851...3,844,645
Ensembl chr25:3,779,197...3,841,321
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA, protein:increased expression:neuron
RGD
PMID:19833109
RGD:5133729
NCBI chr10:33,904,065...34,021,549
Ensembl chr10:33,886,343...34,021,696
G
GP6
glycoprotein VI platelet
exacerbates
ISO
RGD
PMID:21258336
RGD:401824683
NCBI chr 1:102,586,229...102,612,067
Ensembl chr 1:102,585,544...102,613,905
G
MDM2
MDM2 proto-oncogene
treatment
ISO
RGD
PMID:34334113
RGD:155882538
NCBI chr10:10,936,288...10,963,118
Ensembl chr10:10,893,719...10,962,596
G
ZEB2
zinc finger E-box binding homeobox 2
treatment
ISO
protein:increased expression:brain (rat)
RGD
PMID:34334113
RGD:155882538
NCBI chr19:46,419,812...46,541,888
Ensembl chr19:46,423,998...46,542,122
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
ISO
mRNA:decreased expression:bone
RGD
PMID:19607804
RGD:5147852
NCBI chr 1:31,522,911...31,525,342
Ensembl chr 1:31,523,799...31,524,995
G
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23992905
RGD:12911207
NCBI chr37:25,616,942...25,622,989
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:motor neuron
RGD
PMID:21456016
RGD:5684341
NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
G
ADCY10
adenylate cyclase 10
ISO
protein:decreased expression:retina
RGD
PMID:22649251
RGD:329347828
NCBI chr 7:30,576,445...30,660,926
Ensembl chr 7:30,577,591...30,660,926
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:18414890
RGD:2312783
NCBI chr24:37,211,776...37,245,938
Ensembl chr24:37,213,942...37,243,702
G
AMIGO3
adhesion molecule with Ig like domain 3
treatment
ISO
RGD
PMID:23613963
RGD:14390159
NCBI chr20:39,554,028...39,557,129
Ensembl chr20:39,554,629...39,556,155
G
AQP4
aquaporin 4
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
AQP9
aquaporin 9
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr30:23,223,413...23,271,893
Ensembl chr30:23,225,331...23,269,076
G
ARG2
arginase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30618589
NCBI chr 8:41,588,051...41,619,406
Ensembl chr 8:41,588,150...41,619,402
G
ATF2
activating transcription factor 2
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr36:19,032,376...19,103,382
Ensembl chr36:19,010,717...19,103,292
G
BAX
BCL2 associated X, apoptosis regulator
ISO
mRNA:increased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA:decreased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:9520478 PMID:11050383 PMID:15140649
RGD:8655584 RGD:8655586 RGD:8655637
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
C3
complement C3
ISO
mRNA:increased expression:optic nerve
RGD
PMID:14577867
RGD:5129542
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CDK2
cyclin dependent kinase 2
ISO
mRNA:increased expression:retina
RGD
PMID:16723461
RGD:2293567
NCBI chr10:300,863...306,546
Ensembl chr10:300,903...305,438
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:27443501
RGD:11568693
NCBI chr18:51,404,649...51,408,240
Ensembl chr18:51,401,659...51,408,212
G
CLU
clusterin
ISO
RGD
PMID:14577867
RGD:5129542
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
CSF1R
colony stimulating factor 1 receptor
ISO
mRNA:increased expression:retina (rat)
RGD
PMID:20187850
RGD:151665810
NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:20144610
RGD:11039471
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
G
CTSB
cathepsin B
ISO
protein:increased expression:retina (rat)
RGD
PMID:18775855
RGD:2315508
NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801
G
EDN1
endothelin 1
ISO
protein:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
EDNRA
endothelin receptor type A
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr15:45,823,472...45,878,527
Ensembl chr15:45,823,560...45,876,463
G
EDNRB
endothelin receptor type B
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr22:31,415,324...31,438,772
Ensembl chr22:31,417,308...31,437,587
G
EP300
E1A binding protein p300
ISO
human gene in rat model
RGD
PMID:21705428
RGD:7349392
NCBI chr10:24,076,538...24,156,708
Ensembl chr10:24,077,971...24,156,396
G
FGF2
fibroblast growth factor 2
treatment
ISO
RGD
PMID:14664816
RGD:8554854
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:retina
RGD
PMID:33664770
RGD:329951020
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
GDNF
glial cell derived neurotrophic factor
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr 4:70,966,694...70,991,860
Ensembl chr 4:70,971,432...70,989,714
G
GFRA1
GDNF family receptor alpha 1
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr28:26,707,592...26,910,029
Ensembl chr28:26,709,645...26,909,992
G
GFRA2
GDNF family receptor alpha 2
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr25:35,436,790...35,521,661
Ensembl chr25:35,436,317...35,520,365
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:21443522
RGD:8548549
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:increased expression:retina: protein: altered activity: eye
RGD
PMID:19484445 PMID:23648097
RGD:10046025 RGD:5686431
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr 5:50,966,698...50,968,939
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr38:22,114,718...22,143,625
Ensembl chr38:22,130,508...22,140,813
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
ISO
mRNA:increased expression:retina
RGD
PMID:12076086
RGD:8662362
NCBI chr MT:5,349...6,893
Ensembl chr MT:5,349...6,893
G
MYRF
myelin regulatory factor
ISO
mRNA:decreased expression: oligodendrocyte
RGD
PMID:29915135
RGD:213230153
NCBI chr18:54,690,073...54,723,046
Ensembl chr18:54,692,453...54,723,085
G
NAMPT
nicotinamide phosphoribosyltransferase
treatment
ISO
RGD
PMID:28032230
RGD:13781885
NCBI chr18:14,110,045...14,211,268
Ensembl chr18:13,993,022...14,208,657
G
NCAM1
neural cell adhesion molecule 1
ISO
RGD
PMID:18757519
RGD:2326023
NCBI chr 5:19,895,587...20,192,334
Ensembl chr 5:19,895,613...20,191,995
G
NEFM
neurofilament medium chain
ISO
RGD
PMID:8501527
RGD:9743936
NCBI chr25:32,493,517...32,498,615
Ensembl chr25:32,493,675...32,498,570
G
NEO1
neogenin 1
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr30:36,387,425...36,622,491
Ensembl chr30:36,387,259...36,622,154
G
NGF
nerve growth factor
ISO
protein:increased expression:retina
RGD
PMID:28067793
RGD:402463954
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
NGFR
nerve growth factor receptor
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr 9:25,598,468...25,621,021
Ensembl chr 9:25,601,074...25,623,274
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288
G
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:20357199 PMID:34245756
RGD:5684908 RGD:597015764
NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA:increased expression:retina:
RGD
PMID:12836167
RGD:1299297
NCBI chr15:22,114,014...22,159,287
G
PAX6
paired box 6
ISO
protein:increased expression:retina (rat)
RGD
PMID:23297010
RGD:8552379
G
PDGFB
platelet derived growth factor subunit B
ISO
protein:decreased expression:nerve fiber:
RGD
PMID:9893812
RGD:10449496
NCBI chr10:25,798,877...25,819,422
Ensembl chr10:25,798,938...25,817,746
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:optic nerve (rat)
RGD
PMID:22336118
RGD:6767293
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PLAU
plasminogen activator, urokinase
ISO
mRNA:increased expression:optic nerve (rat)
RGD
PMID:20798533
RGD:6483802
NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
G
PTPN5
protein tyrosine phosphatase non-receptor type 5
ISO
protein:increased expression:retina (rat)
RGD
PMID:15555919
RGD:9835027
NCBI chr21:41,097,563...41,154,247
Ensembl chr21:41,097,569...41,136,706
G
RHOA
ras homolog family member A
ISO
protein:increased expression, altered localization:retina
RGD
PMID:17534117
RGD:1642826
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
G
SNW1
SNW domain containing 1
ISO
protein:increased expression:retina (rat)
RGD
PMID:25074585
RGD:11035254
NCBI chr 8:50,478,924...50,512,360
Ensembl chr 8:50,479,338...50,512,243
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:19661221
RGD:597538516
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TLR4
toll like receptor 4
ISO
protein:increased expression:optic nerve
RGD
PMID:23103505
RGD:7794777
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:14697498 PMID:18552980
RGD:7794683 RGD:8661743
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TRADD
TNFRSF1A associated via death domain
ISO
protein:increased expression: retina
RGD
PMID:18552980
RGD:7794683
NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
G
YBX3
Y-box binding protein 3
ISO
mRNA:increased expression:retinal ganglion cell
RGD
PMID:11750989
RGD:2311250
NCBI chr27:35,043,756...35,066,230
Ensembl chr27:35,043,699...35,066,227
G
ZC3H7B
zinc finger CCCH-type containing 7B
ISO
protein:decreased expression:retinal ganglion cell layer (rat)
RGD
PMID:21705428
RGD:7349392
NCBI chr10:23,882,379...23,944,850
Ensembl chr10:23,884,981...23,920,131
G
FGF2
fibroblast growth factor 2
ISO
mRNA:increased expression:retina
RGD
PMID:9268592
RGD:8655567
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
NEO1
neogenin 1
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr30:36,387,425...36,622,491
Ensembl chr30:36,387,259...36,622,154
G
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr 3:47,044,342...47,089,923
Ensembl chr 3:47,061,910...47,089,294
G
ENTPD1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
protein:increased expression,increased activity:cerebral cortex:
RGD
PMID:16672190
RGD:9685448
NCBI chr28:9,181,851...9,311,835
Ensembl chr28:9,211,050...9,323,939
G
FGFR1
fibroblast growth factor receptor 1
ISO
mRNA,protein:increased expression:astrocyte,macrophage,neutrophil:
RGD
PMID:11168551
RGD:10402049
NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
G
GFAP
glial fibrillary acidic protein
ISO
RGD
PMID:10225952
RGD:6480471
NCBI chr 9:18,569,868...18,579,463
Ensembl chr 9:18,569,892...18,579,461
G
PDGFB
platelet derived growth factor subunit B
ISO
protein:increased expression:neuron:
RGD
PMID:7526956
RGD:10449485
NCBI chr10:25,798,877...25,819,422
Ensembl chr10:25,798,938...25,817,746
G
VIM
vimentin
ISO
RGD
PMID:10225952
RGD:6480471
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
G
TRH
thyrotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8690305
NCBI chr20:5,219,495...5,222,914
Ensembl chr20:5,219,594...5,222,866
G
BMP4
bone morphogenetic protein 4
treatment
ISO
RGD
PMID:16332232
RGD:8699514
NCBI chr 8:29,997,563...30,254,307
Ensembl chr 8:29,997,569...30,004,557
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1899364
NCBI chr16:23,469,590...23,496,013
G
ADAM10
ADAM metallopeptidase domain 10
ISO
RGD
PMID:22489706
RGD:13703033
NCBI chr30:23,605,724...23,732,038
Ensembl chr30:23,606,517...23,731,823
G
AHR
aryl hydrocarbon receptor
ISO
protein:increased expression:T cell, neuron, brain cortex, hippocampus
RGD
PMID:27506546
RGD:405878081
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
APP
amyloid beta precursor protein
treatment
ISO
RGD
PMID:29320530
RGD:13782048
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
G
B9D2
B9 domain containing 2
treatment
ISO
RGD
PMID:28433746
RGD:14995478
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:24582457
RGD:13782254
NCBI chr18:52,781,335...52,791,789
Ensembl chr18:52,781,921...52,791,405
G
BDNF
brain derived neurotrophic factor
ISO
mRNA:increased expression:CA3 field of hippocampus, dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
BID
BH3 interacting domain death agonist
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:5509821 RGD:632018
NCBI chr27:45,344,304...45,355,735
Ensembl chr27:45,337,145...45,384,059
G
CAPN1
calpain 1
severity
ISO
protein:increased expression:cytosol, plasma membrane
RGD
PMID:9469158 PMID:15307896
RGD:13792664 RGD:5509821
NCBI chr18:51,983,266...52,010,831
Ensembl chr18:51,983,824...52,010,757
G
CAPN2
calpain 2
severity
ISO
RGD
PMID:9469158 PMID:15307896
RGD:13792664 RGD:5509821
NCBI chr 7:40,333,379...40,367,158
Ensembl chr 7:40,334,012...40,377,037
G
CASP3
caspase 3
severity
ISO
protein:increased expression:cerebral cortex
RGD
PMID:15307896 PMID:27614125
RGD:329961568 RGD:5509821
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP8
caspase 8
severity disease_progression
ISO
RGD
PMID:12172380 PMID:15307896
RGD:5509821 RGD:632018
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
CASP9
caspase 9
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:5509821 RGD:632018
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
G
CCNG1
cyclin G1
treatment
ISO
RGD
PMID:18612315 PMID:24398934
RGD:151356934 RGD:151356935
NCBI chr 4:47,800,697...47,808,259
Ensembl chr 4:47,801,575...47,808,211
G
CD163
CD163 molecule
ISO
protein:increased expression:brain, macrophage (rat)
RGD
PMID:22583855
RGD:127285798
NCBI chr27:37,669,757...37,700,746
Ensembl chr27:37,669,827...37,753,106
G
CD8A
CD8 subunit alpha
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:31383034
RGD:124715446
NCBI chr17:38,396,022...38,400,508
Ensembl chr17:38,369,414...38,400,508
G
CIT
citron rho-interacting serine/threonine kinase
ISO
mRNA:decreased expression:cerebral cortex��(rat)
RGD
PMID:12503083
RGD:2317873
NCBI chr26:15,721,500...15,885,133
Ensembl chr26:15,723,690...15,884,343
G
CTNNB1
catenin beta 1
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
ISO
RGD
PMID:26435412
RGD:27095897
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr28:2,895,916...2,903,543
G
CYP2D15
cytochrome P450 family 2 subfamily D member 15
treatment
ISO
RGD
PMID:26068867
RGD:401901590
NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
G
DRD1
dopamine receptor D1
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr 4:37,550,454...37,554,641
Ensembl chr 4:37,549,708...37,553,287
G
DRD2
dopamine receptor D2
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
FUBP1
far upstream element binding protein 1
ISO
RGD
PMID:23797733
RGD:13673879
NCBI chr 6:68,923,215...68,963,766
G
GNAL
G protein subunit alpha L
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr 7:77,378,134...77,521,215
Ensembl chr 7:77,413,986...77,521,042
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
protein:increased phosphorylation:central amygdaloid nucleus (rat)
RGD
PMID:30638118
RGD:405101698
NCBI chr 4:55,801,269...56,103,383
Ensembl chr 4:55,803,296...56,103,669
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
ITGB1
integrin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 2:3,728,472...3,757,696
Ensembl chr 2:3,670,596...3,756,961
G
LAMA1
laminin subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 7:73,309,383...73,438,543
Ensembl chr 7:73,309,388...73,448,151
G
LAMP2
lysosomal associated membrane protein 2
ISO
protein:increased expression:hippocampus:
RGD
PMID:28365875
RGD:13703062
NCBI chr X:92,405,946...92,444,527
Ensembl chr X:92,407,950...92,444,765
G
LCN2
lipocalin 2
ISO
RGD
PMID:31539545
RGD:126781751
NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:25771151 PMID:26484783 PMID:26729399 PMID:28412141
RGD:13800902 RGD:13800909 RGD:13800912 RGD:13800917
NCBI chr 9:9,572,174...9,674,082
Ensembl chr 9:9,570,557...9,674,349
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr32:37,653,163...37,679,577
Ensembl chr32:37,653,035...37,678,398
G
MIR155
microRNA mir-155
ISO
RGD
PMID:28804446
RGD:25314324
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MMP2
matrix metallopeptidase 2
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
NCSTN
nicastrin
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr38:21,878,071...21,891,362
Ensembl chr38:21,685,868...21,892,097
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:brain:
RGD
PMID:30855558
RGD:26884463
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NGF
nerve growth factor
treatment
ISO
RGD
PMID:26285082
RGD:402463964
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
NMNAT1
nicotinamide nucleotide adenylyltransferase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr 5:63,122,379...63,152,078
Ensembl chr 5:63,122,498...63,151,661
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOX1
NADPH oxidase 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr X:74,784,627...74,811,796
Ensembl chr X:74,785,168...74,811,698
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
protein:increased phosphorylation:amygdala mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:30638118 PMID:36637480
RGD:405101698 RGD:408364984
NCBI chr 2:38,124,568...38,242,510
Ensembl chr 2:38,123,190...38,240,755
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
G
OCLN
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 2:54,500,299...54,545,430
Ensembl chr 2:54,500,299...54,545,430
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829224 PMID:28642177
NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
G
PDE10A
phosphodiesterase 10A
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr 1:53,457,781...54,049,735
Ensembl chr 1:53,462,979...53,801,966
G
PDYN
prodynorphin
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12626770
RGD:633616
NCBI chr24:19,043,955...19,057,413
Ensembl chr24:19,053,870...19,056,364
G
PHACTR1
phosphatase and actin regulator 1
treatment
ISO
RGD
PMID:36571365
RGD:401901253
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
PPP3R1
protein phosphatase 3 regulatory subunit B, alpha
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr10:67,242,552...67,308,469
Ensembl chr10:67,244,329...67,275,487
G
PPP3R2
protein phosphatase 3 regulatory subunit B, beta
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr11:58,295,237...58,295,942
G
PSEN1
presenilin 1
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr 8:46,495,551...46,569,532
Ensembl chr 8:46,495,624...46,569,532
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593 PMID:28642177
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
SOX2
SRY-box transcription factor 2
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr34:14,853,000...14,855,153
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TP53
tumor protein p53
treatment
ISO
RGD
PMID:27553877
RGD:14995939
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
UBE4B
ubiquitination factor E4B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr 5:63,214,846...63,339,218
Ensembl chr 5:63,215,470...63,338,215
G
WNT3A
Wnt family member 3A
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr14:864,393...899,698
Ensembl chr14:863,424...896,412
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20370756
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
G
ABCC8
ATP binding cassette subfamily C member 8
treatment
ISO
RGD
PMID:18854840
RGD:2325137
NCBI chr21:39,963,001...40,037,040
Ensembl chr21:39,962,947...40,036,981
G
TP53
tumor protein p53
ISO
RGD
PMID:22977862
RGD:8547771
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
ADRB2
adrenoceptor beta 2
ISO
mRNA:increased expression:Vestibulocochlear nerve:
RGD
PMID:22178544
RGD:8548530
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all